Oragenics Inc OGEN:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
1.05quote price arrow up+0.03 (+2.94%)
Volume
145,599
Close
1.02quote price arrow down-0.03 (-2.86%)
Volume
5,453,249
52 week range
0.36 - 2.09

...

Loading . . .

KEY STATS

  • Open1.03
  • Day High1.08
  • Day Low0.98
  • Prev Close1.05
  • 52 Week High2.09
  • 52 Week High Date07/22/20
  • 52 Week Low0.36
  • 52 Week Low Date04/16/20
  • Market Cap93.61M
  • Shares Out91.77M
  • 10 Day Average Volume9.49M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • 1 Year % Change74.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.50
  • P/E (TTM)-2.04
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-25.693M
  • ROE (MRQ)-305.52%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)4.90%

EVENTS

  • Earnings Date03/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Oragenics Inc News

There is no recent news for this security.

Latest OGEN News From Our Partners

QUOTE FINDER

Profile

MORE
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have...
Frederick Telling Ph.D.
Chairman
Alan Joslyn Ph.D.
President
Michael Sullivan CPA
Chief Financial Officer
Address
4902 Eisenhower Blvd Ste 125
Tampa, FL
33634-6342
United States